Impact of perfusion lesion in corticospinal tract on response to reperfusion

Eur Radiol. 2017 Dec;27(12):5280-5289. doi: 10.1007/s00330-017-4868-y. Epub 2017 May 24.

Abstract

Objectives: We aimed to examine the impact of corticospinal tract (CST) involvement in acute ischaemic stroke (AIS) patients on functional outcome and the interaction with reperfusion.

Methods: We retrospectively examined data in consecutive anterior circulation AIS patients undergoing thrombolysis. MR perfusion (time to maximum of tissue residue function, Tmax) and apparent diffusion coefficient (ADC) images were transformed into standard space and the volumes of CST involvement by Tmax > 6 s (CST-Tmax) and ADC < 620 × 10-6 mm2/s (CST-ADC) lesions were calculated. Good outcome was defined as modified Rankin scale ≤ 2 at 3 months. Reperfusion was defined as a reduction in Tmax > 6 s lesion volume of ≥70% between baseline and 24 h.

Results: 82 patients were included. Binary logistic regression revealed that both CST-Tmax and CST-ADC volume at baseline were significantly associated with poor outcome (p < 0.05). The 24-h CST-ADC volume was correlated with baseline CST-ADC volume in patients with reperfusion (r = 0.79, p < 0.001) and baseline CST-Tmax volume in patients without reperfusion (r = 0.67, p < 0.001). In patients with CST-Tmax volume > 0 mL and CST-ADC volume < 3 mL, the rate of good outcome was higher in patients with reperfusion than those without (70.4% vs 38.1%, p = 0.04).

Conclusions: The use of CST-Tmax in combination with CST-ADC provides prognostic information in patients considered for reperfusion therapies.

Key points: • Examine the impact of corticospinal tract involvement in acute ischaemic stroke patients. • Spatially registered Tmax images can identify corticospinal tract hypoperfusion injury. • Corticospinal tract salvage through reperfusion is associated with improved outcome.

Keywords: Corticospinal tract; Magnetic resonance imaging; Prognosis; Stroke; Thrombolytic therapy.

MeSH terms

  • Acute Disease
  • Aged
  • Brain Ischemia / diagnosis*
  • Brain Ischemia / drug therapy
  • Brain Ischemia / physiopathology
  • Cerebrovascular Circulation / physiology*
  • Diffusion Magnetic Resonance Imaging / methods*
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Image Processing, Computer-Assisted
  • Male
  • Prognosis
  • Pyramidal Tracts / blood supply
  • Pyramidal Tracts / diagnostic imaging*
  • Retrospective Studies
  • Thrombolytic Therapy / methods*

Substances

  • Fibrinolytic Agents